Veterinary Vaccines Market to Surpass US$ 9.4 Billion by 2024

Veterinary/Animal Vaccines – Ensure good health of human’s best friends

Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat, and other poultry products. Veterinary biologics are governed by the U.S. Department of Agriculture (USDA) Center for Veterinary Biologics. To combat increasing prevalence of potentially fatal veterinary diseases, there’s a significant spike in demand for combination vaccines that allow for greater accuracy and stability of the finished product. Regulations are also focusing on improving stability, consistency and quality of vaccines produced. Maintaining the quality of production will circumvent risk of side effects.

As per the American Veterinary Medical Foundation, core vaccines such as rabies, feline viral rhinotracheitis, feline panleukopenia, canine parvovirus infection, and canine hepatitis are recommended for every pet, while non-core vaccines such as canine kennel cough and feline leukemia are recommended based on specific needs of the animal. However, low awareness among pet owners and livestock managers inhibits the growth of veterinary vaccines market, especially in emerging economies.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/125

The global veterinary vaccines market was valued at US$ 5,688.7 million in 2015 and is expected to witness a moderate CAGR of 5.9% during the forecast period (2016 – 2024).

Increasing incidence of veterinary diseases to drive the growth of veterinary vaccines market

According to the 2015 Global Animal Disease Intelligence Report by the Food and Agriculture Organization (FAO), prevalence of foot-and-mouth disease (FMD) was especially high in Morocco, Saudi Arabia, Turkey, Northern, and Southern Africa. Ebola (Zoonotic disease) continued to be prevalent in West Africa. Also, rabies that leads to thousands of human deaths worldwide is prevalent in 150 countries according to the WHO, with highest number of related deaths reported in Asia and Africa. Thus, these regions are amongst the largest target regions for veterinary vaccines market. Incidence rate of rabies has reduce drastically in Latin America and Caribbean regions due to successful implementation dog rabies control programs.

Growing pet adoption and livestock animals to improve the veterinary vaccines market outlook

As per 2016 Pet Secure (a pet rescue organization in Australia) estimates, dog population is highest in the U.S. at 69,929,000. Pet owners in the country spend over US$ 50 billion on maintenance of their pets. However, pet adoption in Asia Pacific and Latin America regions is increasing rapidly according to the Pet Asia Fair in 2016, resulting in increase in demand for vaccines in these regions. China, Russia and Brazil are leading countries in terms of cat and dog population as per the 2016 estimates of Pet Secure. Also, the organization mentions that the population of dogs in Switzerland is shrinking while increasing rapidly in India. These regional trends of pet adoption need to be essentially factored for by the companies to increase share in the global veterinary vaccines market.

You can also get exclusive discount on this CMI report by clicking on this link: https://www.coherentmarketinsights.com/insight/request-discount/125

Evolving technology improving the affordability of veterinary vaccines

Cell culture has enabled mass production of vaccines. Adoption of cell culture technology for parenteral veterinary vaccine production is increasing in emerging economies in Asia as per the World Health Organization (WHO). Highly immunogenic inactivated cell culture parenteral vaccines for dogs are now available at an affordable costs in emerging economies. Moreover, according to the WHO, trials for oral immunization of dogs are underway in these regions. This is expected to benefit one of the larger section of veterinary vaccination consumer base. Also, third generation vaccines are being produced using recombinant technology. Increasing implantation of advanced production technologies is expected to significantly decrease costs of veterinary vaccines and in turn increase their adoption in cost-sensitive emerging economies characterized by large pet and livestock population.

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Visit Blog: http://healthcaremarketconsulting.blogspot.in/

%d bloggers like this: